Stephen Sullivan

Stephen Sullivan is a seasoned regulatory operations professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Director of Regulatory Operations at MBX Biosciences, Inc. since May 2024, Stephen has held significant roles at various esteemed organizations, including director positions at Ipsen and Albireo Pharma, where responsibilities included regulatory operations and publishing. With a comprehensive background that includes consultancy work at Vertex Pharmaceuticals and freelance specialization in eCTD, Stephen has cultivated expertise in regulatory compliance and operations management. Stephen holds a BA in Mathematics from Fordham University, complemented by further education in ECD.